Compare · MHUA vs SYK
MHUA vs SYK
Side-by-side comparison of Meihua International Medical Technologies Co. Ltd. (MHUA) and Stryker Corporation (SYK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MHUA and SYK operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- SYK carries a market cap of $112.48B.
- SYK has hit the wire 8 times in the past 4 weeks while MHUA has been quiet.
- SYK has more recent analyst coverage (25 ratings vs 0 for MHUA).
- Company
- Meihua International Medical Technologies Co. Ltd.
- Stryker Corporation
- Price
- $7.61-45.80%
- $294.69+0.46%
- Market cap
- -
- $112.48B
- 1M return
- -65.53%
- -
- 1Y return
- -75.05%
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- 2022
- News (4w)
- 0
- 8
- Recent ratings
- 0
- 25
Meihua International Medical Technologies Co. Ltd.
Meihua International Medical Technologies Co., Ltd. engages in the manufacture and marketing of medical consumables in the People's Republic of China. It offers class I, II, and III disposable medical devices. The company's products include non-bottled products, such as brushes and ID bracelets; and polyethylene bottled products, such as eye drop and tablet bottles. It also distributes disposable medical devices sourced from other manufacturers to customers in China. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China. Meihua International Medical Technologies Co., Ltd. operates as a subsidiary of Bright Accomplish Limited.
Stryker Corporation
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Latest MHUA
- SEC Form 6-K filed by Meihua International Medical Technologies Co. Ltd.
- Meihua International Medical Technologies Co., Ltd. Received Nasdaq Delisting Notice
- Meihua International Announces 1-For-100 Reverse Share Split
- SEC Form 6-K filed by Meihua International Medical Technologies Co. Ltd.
- SEC Form 6-K filed by Meihua International Medical Technologies Co. Ltd.
- SEC Form 6-K filed by Meihua International Medical Technologies Co. Ltd.
- SEC Form 6-K filed by Meihua International Medical Technologies Co. Ltd.
- SEC Form 6-K filed by Meihua International Medical Technologies Co. Ltd.
- SEC Form 6-K filed by Meihua International Medical Technologies Co. Ltd.
- SEC Form 424B3 filed by Meihua International Medical Technologies Co. Ltd.
Latest SYK
- Stryker launches Sonopet® 3, delivering greater power and precision in ultrasonic tissue removal
- Stryker and CMR Surgical announce strategic alliance to advance robotic-assisted surgery
- Barclays initiated coverage on Stryker with a new price target
- SEC Form 8-K filed by Stryker Corporation
- Stryker announces leadership succession
- Stryker to announce third quarter 2026 financial results
- VP, Chief Financial Officer Wells Preston Wendell disposed of 109 shares, decreasing direct ownership by 3% to 3,661 units (SEC Form 4)
- VP, Chief Financial Officer Wells Preston Wendell disposed of 2,739 shares, decreasing direct ownership by 42% to 3,770 units (SEC Form 4)
- Stryker showcases Foot & Ankle innovation at AOFAS 2026 with Prophecy® Surgical Planning for Incompass™ and Hoffmann® LRF smartHEX™
- New insider Baculik Emily Kay claimed ownership of 1,554 shares (SEC Form 3)